Oncternal Therapeutics, Inc.·4

Jul 5, 6:58 PM ET

Yazji Salim 4

4 · Oncternal Therapeutics, Inc. · Filed Jul 5, 2023

Insider Transaction Report

Form 4
Period: 2023-07-03
Yazji Salim
Chief Medical Officer
Transactions
  • Tax Payment

    Common Stock

    2023-07-03$0.36/sh16,299$5,868148,377 total
Footnotes (1)
  • [F1]Shares withheld by the Issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION